Skip to content

Upadacitinib repigments ~1 in 5 with vitiligo vs 6% placebo

August 15, 2026 · 12 min

Show notes

Editor's Pick: Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies (The Lancet, 2026)

Welcome to This Week in Dermatology. This week we're covering 10 notable papers spanning the expanding reach of oral JAK inhibitors into vitiligo and alopecia areata, safety and risk stratification at the intersection of skin disease and cancer, and evolving standards for how we define and deliver care in atopic dermatitis and scarring. Let's dive in.

This week's papers:

  1. Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.. The Lancet 2026
  2. Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.. JAMA Dermatology 2026
  3. Targeted therapies for psoriasis and atopic dermatitis in the context of malignancy: SPIN-FRT recommendations.. Journal of the European Academy of Dermatology and Venereology 2026
  4. Alopecia areata as a sentinel condition for systemic autoimmunity: a global bidirectional cohort study.. Dermatology 2026
  5. Risk Stratification Models for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.. JAMA Dermatology 2026
  6. Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.. Journal of the American Academy of Dermatology 2026
  7. Real-world Effectiveness and Safety of Lebrikizumab in Atopic Dermatitis: A TREATgermany Analysis.. Acta Dermato-Venereologica 2026
  8. Redefining Treat-to-target in Atopic Dermatitis: Towards Meaningful, Patient-centred Disease Control - An ISAD Position Paper.. Acta Dermato-Venereologica 2026
  9. Consensus on energy-based devices for keloids and hypertrophic scars: A Latin American Delphi study.. Journal of the European Academy of Dermatology and Venereology 2026
  10. Immunosuppression Outweighs Clinical AEIOU Heuristics in Predicting Disease Progression of Merkel Cell Carcinoma: A Retrospective Cohort Study.. Acta Dermato-Venereologica 2026

Listen at AudioScholar

All episodes of AudioScholar Dermatology Weekly (India)

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.